Perioperative reliability of an on-site prothrombin time assay under different haemostatic conditions by Zalunardo, M P et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 1998
Perioperative reliability of an on-site prothrombin time assay under different
haemostatic conditions
Zalunardo, M P; Zollinger, A; Seifert, Burkhardt; Patti, M; Pasch, T
Abstract: Perioperative use of laboratory coagulation assays is limited by the delay in obtaining results.
The management of haemostasis during major surgical procedures requires rapid and accurate measure-
ment of the prevailing coagulation status. In this prospective study, we have evaluated the reliability of
on-site prothrombin time assessed by the portable coagulation monitor CoaguChek-Plus compared with
standard laboratory assays during elective non-cardiac surgery. Sixty-two patients were assigned to one
of three groups: group A = normal preoperative coagulation where minor intraoperative blood loss is
expected; group B = normal preoperative coagulation where major intraoperative blood loss is expected;
and group C = preoperative anticoagulation and minor intraoperative blood loss expected. On-site pro-
thrombin time and laboratory prothrombin time showed poor correlation in group A (r2 = 0.24; bias (2
SD) 1.80 (3.34) S) and group B (r2 = 0.30; 1.43 (3.12) S). The correlation in group C was better (r2 =
0.71; 1.41 (1.92) S). We conclude that prothrombin time measured with the CoaguCheck-Plus monitor
did not appear to be suitable for the management of haemostasis.
DOI: https://doi.org/10.1093/bja/81.4.533
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-113313
Journal Article
Published Version
Originally published at:
Zalunardo, M P; Zollinger, A; Seifert, Burkhardt; Patti, M; Pasch, T (1998). Perioperative reliability of
an on-site prothrombin time assay under different haemostatic conditions. British Journal of Anaesthesia,
81(4):533-536.
DOI: https://doi.org/10.1093/bja/81.4.533
British Journal of Anaesthesia 1998; 81: 533–536 
Perioperative reliability of an on-site prothrombin time assay under 
different haemostatic conditions 
M. P. ZALUNARDO, A. ZOLLINGER, B. SEIFERT, M. PATTI AND T. PASCH 
 
Summary 
Perioperative use of laboratory coagulation 
assays is limited by the delay in obtaining 
results. The management of haemostasis during 
major surgical procedures requires rapid and 
accurate measurement of the prevailing coagu- 
lation status. In this prospective study, we have 
evaluated the reliability of on-site prothrombin 
time assessed by the portable coagulation moni- 
tor CoaguChek-Plus compared with standard 
laboratory assays during elective non-cardiac 
surgery. Sixty-two patients were assigned to one 
of three groups: group Anormal preoperative 
coagulation where major intraoperative blood 
loss is expected; and group Bnormal preoperative 
coagulation where minor intraoperative blood 
loss is expected; and group Cpreoperative anti- 
coagulation and minor intraoperative blood loss 
expected. On-site prothrombin time and labora- 
tory prothrombin time showed poor correlation 
in group A (r20.24; bias (2 SD) 1.80 (3.34) s) and 
group B (r20.30; 1.43 (3.12) s). The correlation in 
group C was better (r20.71; 1.41 (1.92) s). We 
conclude that prothrombin time measured with 
the CoaguChek-Plus monitor did not appear to 
be suitable for the management of haemostasis. 
(Br. J. Anaesth. 1998; 81: 533536). 
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Intraoperative assessment of coagulation is of major 
concern, as it may alter rapidly during surgery as a 
result of both major blood loss and volume replace- 
ment with colloids, crystalloids and blood compo- 
nents.1 Furthermore, an increasing number of 
patients with compromised haemostatic potential 
present for surgery. The prothrombin time (PT) 
assay is used in the perioperative period as a routine 
measure of the extrinsic pathway of coagulation. The 
clinical use of most laboratory coagulation assays, 
including PT, continues to be restricted by the delay 
in obtaining results. Rapid determination of PT may 
be helpful in the case of major bleeding and coagu- 
lopathy. Despotis and colleagues demonstrated that 
the use of on-site coagulation assays can reduce the 
use of blood products, decrease operating time and 
minimize chest tube drainage in cardiac surgery.2 
The portable coagulation monitor CoaguChek- 
Plus (Boehringer Mannheim, Germany, formerly 
Biotrack 512, Ciba-Corning, Medfield, MA, USA) 
has been shown to measure accurately intraoperative 
on-site PT in less than 3 min.3 4 Comparison of 
results with those of standard laboratory assays has 
been made in cardiac2–5 and gynaecological surgery.6 
The purpose of our prospective study was to evaluate 
the reliability of CoaguChek-Plus prothrombin time 
(CC-PT) in comparison with simultaneous standard 
laboratory prothrombin time (LAB-PT) assays under 
different haemostatic conditions during elective non- 
cardiac surgery. 
Patients and methods 
After obtaining approval from the Ethics Committee 
and informed patient consent, we studied 62 patients 
with no history of bleeding. Patients were allocated to 
one of three groups: group Anormal preoperative 
coagulation and minor intraoperative blood loss 
expected; group Bnormal preoperative coagulation 
and major intraoperative blood loss expected; and 
group Cpreoperative oral anticoagulation with 
phenprocoumon (Marcoumar) or acenocoumarol 
(Sintrom), discontinued before surgery, or high-dose 
i.v. heparin. The inclusion criterion for those receiv- 
ing oral anticoagulants was a laboratory PT65% 
(corresponding to an international normalized 
ratio (INR) of 1.4) on the day before surgery. The 
inclusion criterion for patients receiving heparin was 
a daily dose of heparin 15 000 u. (Liquemin). 
Assessment of PT was performed on 3–5 separate 
occasions: (1) before operation, after induction of 
anaesthesia; (2) during operation, up to three times, 
depending on the length of the surgical procedure 
and amount of blood loss and fluid replacement; and 
(3) after operation, before patient transport from the 
operating theatre to the recovery room or intensive 
care unit. 
CC-PT measurements were performed strictly in 
accordance with the manufacturer’s instructions. 
The technical and methodological aspects of the 
CoaguChek-Plus monitor have been described by 
Lucas and colleagues.7 All blood samples were 
obtained from a non-heparinized central venous 
catheter, the catheter being rinsed with 20 ml of 
saline beforehand. 10 ml of blood were withdrawn 
and discarded before sampling. For the CoaguChek- 
Plus, one drop of the sampled blood was applied 
immediately to the inserted CC-PT cartridge. For the 
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standard laboratory assay, 10 ml of whole blood were 
drawn up into a citrate-containing glass tube and 
sent immediately to the laboratory. LAB-PT mea- 
surements were performed using the Electra 1600 C 
(Medical Laboratory Automation, Pleasantville, NY, 
USA) and thromboplastin Innovin (DADE Behring, 
Illinois, USA). The INR, calculated by the 
CoaguChek-Plus monitor, was compared with the 
INR of the laboratory assay. 
STATISTICAL ANALYSIS 
Comparisons between groups (packed cell volume 
(PCV), units of transfused blood) were made using 
analysis of variance (ANOVA) and the Bonferroni– 
Dunn test. Possible trends in the differences in con- 
secutive measurements were analysed by ANOVA for 
repeated measures with the Greenhouse–Geisser 
correction. The correlation between CC-PT and 
LAB-PT measurements was determined by linear 
regression and bias analysis. P0.05 was considered 
statistically significant. The statistical program used 
was Stat View for Windows v. 4.57 (Abacus Concepts 
Inc.) running on an IBM personal computer. 
Results 
PCV values before and after operation and packed 
red blood cell requirements are shown in table 1. 
Preoperative PCV was similar in all groups. Group B 
had a significantly higher intraoperative need for 
packed red blood cells. After operation, following 
blood product use, PCV in group B was significantly 
lower than that in the two other groups. 
Immediate preoperative PT measurements were 
similar in all groups. There was an over-reading 
(bias) of 1.41 s (group C) to 1.80 s (group A) in 
CC-PT compared with LAB-PT (fig. 1). CC-PT and 
LAB-PT correlation values (r2) were 0.24, 0.30 and 
0.71 in groups A, B and C, respectively (fig. 2). 
Expression of PT as INR (logarithmic scale) did not 
improve the correlation between CC-PT and 
LAB-PT, with r2 values of 0.12, 0.12 and 0.73 for 
groups A, B and C, respectively. Extreme outliers in 
group A and B are apparent in figures 1 and 2. 
There was no trend in the accuracy between mea- 
surements before, during and after operation for all 
groups. Furthermore, accuracy was similar for nor- 
mal (PT 13.5 s) and abnormal (PT 13.5 s) ranges 
of PT. Most of the abnormal PT values were found in 
group B. 
Discussion 
We found only a weak correlation between pro- 
thrombin time measured with the CoaguChek-Plus 
monitor and that measured in the laboratory. Several 
outliers contributed substantially to the poor accu- 
racy of the device. In several cases the difference in 
LAB-PT and CC-PT was 10–16 s. Thus the 
CoaguChek-Plus monitor indicated an abnormal PT 
when a normal PT was verified by standard labora- 
tory testing and clinical judgement. These false 
pathological PT values may lead to unnecessary and 
potentially harmful substitution therapy with blood 
products. There were no outliers in group C, but the 
probability of outliers occurring was limited because 
of the low number of comparisons (16 vs 138 and 37 
for groups A and B, respectively). Accordingly, the 
best correlation was found in this group. The poor 
accuracy of the device was found equally for mea- 
surements before, during and after operation, and for 
different ranges of PT. 
In view of the small number of outliers, it might be 
Table 1 Perioperative packed cell volume (PCV) and intraoperative blood transfusion (mean (SD)). 
CC-PTCoaguChek-Plus prothrombin time (PT) measurements; LAB-PTlaboratory PT measurements. 
**P0.01, ***P0.001, significant differences in group B compared with both groups A and C 
 Group A Group B Group C 
Number of comparisons (CC-PT vs LAB-PT) 138 37 16 
Preoperative PCV (%) 37.1 (7.1) 34.7 (10.6) 39.2 (3.9) 
Postoperative PCV (%) 30.9 (6.7) 23.4 (3.7)** 31.2 (3.8) 
Packed red blood cells transfused (ml) 820 (496) 2160 (684)*** 350 
 
Figure 1 Bland Altman plot showing bias (mean of differences) 
and precision (1.96 SD of these differences) of prothrombin time 
obtained by the CoaguChek-Plus monitor (CC-PT) compared 
with prothrombin time measured with standard laboratory assays 
(LAB-PT) in group A (n138; A), group B (n37; B) and group C 
(n16; C), respectively. 
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argued that technical or handling errors may have 
been responsible for inaccurate measurements. 
However, blood sampling, measurements and cali- 
bration were performed carefully by the investigators 
in strict accordance with the recommendations of the 
manufacturer. Moreover, in daily clinical practice, an 
on-site coagulation monitor should be easily and reli- 
ably used by theatre staff. 
The accuracy of measurement of PT with the 
CoaguChek-Plus coagulation monitor has been vali- 
dated in a wide range of medical specialities, such as 
clinical pathology,7–9 haematology,10 cardiac surgery2–5 
and gynaecological surgery.6 Most studies showed 
acceptable accuracy in comparison with standard 
laboratory methods. Jennings, Luddington and 
Baglin evaluated the CoaguChek-Plus for the control 
of oral anticoagulation.8 They compared several 
thromboplastins, including lyophilized rabbit brain 
thromboplastin used in the CoaguChek-Plus moni- 
tor with the “consensus” (mean of all compared INR) 
within the therapeutic range for oral anticoagulation. 
The results showed a clinically and statistically signifi- 
cant overestimation by the CoaguChek-Plus monitor. 
The authors concluded that the CoaguChek-Plus 
would be suitable for decentralized anticoagulant 
monitoring, but should not be used when laboratory 
testing with standard thromboplastin is available. 
The international sensitivity index (ISI), which has 
a logarithmic relationship to INR, describes the indi- 
vidual sensitivity of a thromboplastin compared with 
the WHO (World Health Organisation) reference 
thromboplastin. Tripodi and colleagues determined 
the ISI and precision of the INR of the 
CoaguChek-Plus monitor compared with the sec- 
ondary international WHO reference preparation for 
rabbit thromboplastin.10 ISI was 2.715, which is 
higher than that adopted by the manufacturer 
(2.036), and also higher than the laboratory throm- 
boplastin of our study (0.96). The authors suggested 
that the poor correlation of INR may be caused by 
the high ISI. They also recommended the use of 
more sensitive thromboplastins with lower ISI values 
because these show smaller between-laboratory vari- 
ability. This argument may also explain the worsen- 
ing of the correlation we found in groups A and B 
after expressing PT as INR units. Nevertheless, for 
comparison of PT values, INR is the only relevant 
parameter.11 12 In accordance with Tripodi and col- 
leagues, we would prefer a more sensitive thrombo- 
plastin for on-site PT measurement. 
Despotis and colleagues3 and Reich and 
colleagues5 reported an acceptable accuracy for the 
CoaguChek-Plus monitor in cardiac surgery com- 
pared with laboratory standard assays. Samama and 
colleagues also found good correlations in vascular 
and gynaecological surgery.6 In contrast, Nuttal and 
colleagues found only moderate correlation with 
laboratory assays in their study of 100 patients 
undergoing cardiopulmonary bypass.4 These authors 
concluded that “speeding access” to hospital labora- 
tory results would be a more efficacious alternative. 
In contrast with previous work, we performed 
repeated measurements in individual patients. 
Furthermore, the reliability of the CoaguChek-Plus 
monitor was evaluated under various haemostatic 
conditions. Its accuracy may suffice for the control of 
oral anticoagulation,7–9 but our results indicate that 
CoaguChek-PT measurements are not reliable 
enough for clinical decision making in non-cardiac 
surgery. 
During elective aortic replacement surgery, even 
laboratory PT has been shown to be unreliable for 
assessing coagulation status.13 Within the past 
decade, thrombelastography has become a useful 
adjunct to intraoperative haemostasis management, 
enabling a global assessment of haemostatic func- 
tion.14 Together with the processes of clot formation, 
clot strengthening and clot lysis, even platelet func- 
tion can be determined.15 16 The various thrombelasto- 
graphic variables correlate closely with intraoperative 
coagulopathy and enable selective substitution of 
blood products in accordance with the specific 
requirements of the case.17 If indicated, an accurate 
platelet count may also be obtained on-site.3 
In summary, we advise against the use of the 
CoaguChek-Plus coagulation monitor to evaluate the 
patient’s prevailing prothrombin time or to monitor 
changes during non-cardiac surgery. The associated 
time-saving effect does not compensate for the lack of 
reliability. Perioperative haemostasis management 
should be based primarily on good clinical judgement 
 
Figure 2 Equations of regressionl ines and plots of linear 
regression showing prothrombin time measured using standard 
laboratory assays (LAB-PT) compared with prothrombin time 
obtained by the CoaguChek-Plus monitor (CC-PT) for groups 
A (A), B (B) and C (C). 
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and reliable coagulation testing, such as is provided 
by laboratory coagulation status, when indicated in 
combination with on-site platelet count, on-site acti- 
vated clotting time or thrombelastography.1 3 14–16 
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